TCS
FOLD

Texas Children's’s Amicus Therapeutics FOLD Stock Holding History

Texas Children's’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-45,589
Closed -$620K – 8
2019
Q1 		$620K Sell
45,589
-11,953
-21% -$146K 0.75% 21
2018
Q4 		$551K Buy
+57,542
New +$633K 0.77% 16

Other funds holding FOLD

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Texas Children's's FOLD Position: Q2 2019 in Review

Texas Children's sold out of Amicus Therapeutics (FOLD) in Q2 2019, closing a stake of 45,589 shares — an estimated $620K sold.

Texas Children's first reported a position in FOLD in Q4 2018 and held it in 2 quarters. The position peaked at $620K in Q1 2019. 206 funds tracked by Wall St. Rank hold FOLD as of Q2 2019.

  • Texas Children's reported no remaining Amicus Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Texas Children's sold 45,589 Amicus Therapeutics shares in Q2 2019, an estimated $620K.
  • Texas Children's first reported a position in Amicus Therapeutics in Q4 2018 and held it in 2 quarters.
  • Texas Children's's Amicus Therapeutics position peaked at $620K in Q1 2019.
  • 206 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2019.

Based on Texas Children's's 13F filing for Q2 2019, filed 13 Aug 2019.